Healthtronics Inc

Healthtronics — Healthtronics Surgical Services — Merger or Acquisition (June 2004)

14 slides from Healthtronics's merger presentation, Jun 16, 2004

  1. Slide 1: Prime Medical and HealthTronics

    Slide 1: Prime Medical and HealthTronics

    PRIME MEDICAL EALTHTRON! NASDAQ: PMSI NASDAQ: HTRN

  2. Slide 2: Forward-looking statements

    Slide 2: Forward-looking statements

    This presentation contains forward-looking statements, including those regarding Prime Medical Services, Inc. (“PMSI”) and HealthTronics Surgical Services, Inc. (“HTRN”), their respective subsidiaries and the services they provide. Investors are cautioned that all such statements involve risks and u

  3. Slide 3: Transaction Overview

    Slide 3: Transaction Overview

    TRANSACTION OVERVIEW • Signed Merger Agreement June 11, 2004 • Subject to: Shareholder Approvals from Both Companies Customary Regulatory Approvals • 1:1 stock Exchange Ratio PMSI Shareholders to Receive one HTRN Share for Each PMSI Share • Merged Entity to be called HealthTronics, Inc. • Austin Hea

  4. Slide 4: Board & Senior Management

    Slide 4: Board & Senior Management

    BOARD & SENIOR MANAGEMENT Board of Directors 6 PMSI Nominees 4 HTRN Nominees 1 Joint Nominee Argil Wheelock, M.D. – Chairman Ken Shifrin – Vice Chairman Brad Hummel – CEO & President John Barnidge – CFO & Sr. V.P.

  5. Slide 5: Pro Forma Supplemental Financial Information

    Slide 5: Pro Forma Supplemental Financial Information

    Pro Forma Supplemental Financial Information For the Year Ended December 31, 2004 ProForma (In millions, except per share data) Annual Summary of Projections: Combined Operations PMSI HTRN Synergies Combined Revenues $ 188.3 $ 111.9 $ 300.2 Adjusted EBITDA $ 32.0 $ 12.5 $ 10.0 $ 54.5 Net Income $ 9.

  6. Slide 6: Pro Forma Segment Information

    Slide 6: Pro Forma Segment Information

    Pro Forma Supplemental Financial Information For the Year Ended December 31, 2004 ProForma (In millions, except per share data) 2004 Pro Forma Segment Information PMSI HTRN Combined Revenues: Lithotripsy $ 70.8 $62.7 $ 133.5 Vehicle Manufacturing $ 111.9 $ - $ 111.9 BPH & Cryotherapy $ - $8.4 $ 8.4

  7. Slide 7: Multiple Revenue Sources

    Slide 7: Multiple Revenue Sources

    MULTIPLE REVENUE SOURCES (Combined Pro Forma) Medical Devices Other 9% 1% Lithotripsy 44% Specialty Vehicles 36% Prostatic Orthopaedic 3% Lithotripsy 7%

  8. Slide 8: Pro Forma Balance Sheet Metrics

    Slide 8: Pro Forma Balance Sheet Metrics

    PRO FORMA BALANCE SHEET METRICS Consolidated Balance Sheets As of March 31, 2004 (In millions, except ratios and percentages) PMSI HTRN Combined Assets Current Assets $ 77.8 $ 44.0 $ 121.8 Property & Equipment, net $ 28.1 $ 22.7 $ 50.8 Other Assets $ 195.0 $ 65.1 $ 260.1 Total Assets $ 300.9 $ 131.8

  9. Slide 9: Urology Services

    Slide 9: Urology Services

    UROLOGY SERVICES • Significant Industry Reach and Breadth Approximately 35% Market Share in Lithotripsy Operations in 47 States More than 3,000 Physician Users 70,000 Lithotripsy Procedures 6,000 Prostate Therapy Procedures • Expanding the Urology Platform Leveraging the Provider Network – TUMT – Cr

  10. Slide 10: Urology Services

    Slide 10: Urology Services

    UROLOGY SERVICES • Enhanced Vertical Urology Delivery Litho Partnerships Litho Fee for Service Network Lithotripsy Devices – Medstone STS – HMT Diamond Urology Tables Nationwide Service & Maintenance

  11. Slide 11: Urology Services: Market Drivers

    Slide 11: Urology Services: Market Drivers

    UROLOGY SERVICES • Market Drivers Technology – Innovation Leads Patient Demand Delivery System Shift – Procedure Migration to the ASC and Office Demographics – Aging Population and the Informed Patient

  12. Slide 12: Orthopaedic Lithotripsy

    Slide 12: Orthopaedic Lithotripsy

    ORTHOPAEDIC LITHOTRIPSY • Shock Wave Therapy for Musculoskeletal Injury Plantar Fasciitis (Heel Spur) h Lateral Epicondilitis (Tennis Elbow) • Leading Edge Position Patented Technology (OssaTron™ Device) h FDA Approvals • Key Long-Term Growth Driver 3-4 Million New Cases per Year • Accelerating Payo

  13. Slide 13: Specialty Vehicle Manufacturing

    Slide 13: Specialty Vehicle Manufacturing

    SPECIALTY VEHICLE MANUFACTURING • Leadership Position • Strong Outlook in Homeland Security & Broadcast • Backlog Reveals Strengthening Segment 10% increase from 12/31/03 h 58% rise from 3/31/03 • Plant Consolidation, Fourth Quarter 2004 Expect $2 Million Annual Cost Savings • “Debt-free” Segment

  14. Slide 14: Summary of Merger Benefits

    Slide 14: Summary of Merger Benefits

    SUMMARY OF MERGER BENEFITS Market Prominence Diverse Revenue Streams Expanded Physician Network Vertical Sales Opportunity Improved Capital Structure Accretive

Source: SEC EDGAR · 425 filed Jun 16, 2004

More decks from Healthtronics Inc